HK1199891A1 - 用於克隆和表達關聯抗體可變區基因區段的快速方法 - Google Patents

用於克隆和表達關聯抗體可變區基因區段的快速方法

Info

Publication number
HK1199891A1
HK1199891A1 HK15100396.3A HK15100396A HK1199891A1 HK 1199891 A1 HK1199891 A1 HK 1199891A1 HK 15100396 A HK15100396 A HK 15100396A HK 1199891 A1 HK1199891 A1 HK 1199891A1
Authority
HK
Hong Kong
Prior art keywords
cloning
expression
variable region
gene segments
antibody variable
Prior art date
Application number
HK15100396.3A
Other languages
English (en)
Inventor
Simone Hoege
Erhard Kopetzki
Dominique Ostler
Stefan Seeber
Georg Tiefenthaler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47522537&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1199891(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1199891A1 publication Critical patent/HK1199891A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1086Preparation or screening of expression libraries, e.g. reporter assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0635B lymphocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK15100396.3A 2011-12-21 2015-01-14 用於克隆和表達關聯抗體可變區基因區段的快速方法 HK1199891A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11194861 2011-12-21
PCT/EP2012/076155 WO2013092716A1 (en) 2011-12-21 2012-12-19 Rapid method for cloning and expression of cognate antibody variable region gene segments

Publications (1)

Publication Number Publication Date
HK1199891A1 true HK1199891A1 (zh) 2015-07-24

Family

ID=47522537

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15100396.3A HK1199891A1 (zh) 2011-12-21 2015-01-14 用於克隆和表達關聯抗體可變區基因區段的快速方法

Country Status (12)

Country Link
US (3) US20140302559A1 (zh)
EP (1) EP2794652B1 (zh)
JP (3) JP2015500655A (zh)
KR (1) KR20140104963A (zh)
CN (2) CN104011074A (zh)
BR (1) BR112014013034A2 (zh)
CA (1) CA2854243A1 (zh)
HK (1) HK1199891A1 (zh)
MX (1) MX354049B (zh)
RU (1) RU2612910C2 (zh)
SG (1) SG11201403365TA (zh)
WO (1) WO2013092716A1 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2417156B1 (en) 2009-04-07 2015-02-11 Roche Glycart AG Trivalent, bispecific antibodies
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
CN104945509A (zh) 2009-09-16 2015-09-30 弗·哈夫曼-拉罗切有限公司 包含卷曲螺旋和/或系链的蛋白质复合体及其用途
TW201138821A (en) 2010-03-26 2011-11-16 Roche Glycart Ag Bispecific antibodies
JP5758004B2 (ja) 2010-08-24 2015-08-05 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ジスルフィドによって安定化されたFv断片を含む二重特異性抗体
EP2655413B1 (en) 2010-12-23 2019-01-16 F.Hoffmann-La Roche Ag Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
BR112013019975A2 (pt) 2011-02-28 2017-08-01 Hoffmann La Roche proteínas de ligação de antígeno, composição farmacêutica, uso de uma proteína de ligação de antígeno, método para o tratamento de um paciente e método para a preparação de uma proteína de ligação de antígeno, ácido nucleico, vetor e célula hospedeira"
MX342034B (es) 2011-02-28 2016-09-12 Hoffmann La Roche Proteinas monovalentes que se unen a antigenos.
MX354049B (es) * 2011-12-21 2018-02-09 Hoffmann La Roche Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados.
WO2013119966A2 (en) 2012-02-10 2013-08-15 Genentech, Inc. Single-chain antibodies and other heteromultimers
WO2014001325A1 (en) 2012-06-27 2014-01-03 F. Hoffmann-La Roche Ag Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof
JP6203838B2 (ja) 2012-06-27 2017-09-27 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 少なくとも2つの異なる結合実体を含む、テーラーメイドの高度に選択的かつ多重特異的なターゲティング実体を選択および作製するための方法、ならびにその使用
US20160075766A1 (en) * 2013-05-21 2016-03-17 Roche Diagnostics Operations, Inc. Method for producing antibodies using ovine b-cells and uses thereof
EP3055329B1 (en) 2013-10-11 2018-06-13 F. Hoffmann-La Roche AG Multispecific domain exchanged common variable light chain antibodies
JP6568207B2 (ja) * 2014-05-19 2019-08-28 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ヒツジb細胞を用いて抗体を産生するための方法およびその使用
PL3227332T3 (pl) 2014-12-03 2020-06-15 F. Hoffmann-La Roche Ag Wielospecyficzne przeciwciała
EP3436571B1 (en) 2016-03-30 2023-06-14 F. Hoffmann-La Roche AG B-cell cultivation method
KR20190111036A (ko) * 2016-12-23 2019-10-01 비스테라, 인크. 결합 폴리펩타이드 및 이의 제조 방법
JP6916884B2 (ja) 2017-01-02 2021-08-11 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft B細胞培養法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815909D0 (en) * 1998-07-21 1998-09-16 Btg Int Ltd Antibody preparation
CN100383244C (zh) * 2003-01-07 2008-04-23 西福根有限公司 用于生产重组多克隆蛋白质的方法
US20060051348A1 (en) 2004-09-09 2006-03-09 Jorn Gorlach Method of producing a plurality of isolated antibodies to a plurality of cognate antigens
AU2006290736B2 (en) 2005-09-15 2011-09-15 Crucell Holland B.V. Method for preparing immunoglobulin libraries
EP2021463B1 (en) 2006-05-19 2016-11-23 Alder Biopharmaceuticals, Inc. Culture method for obtaining a clonal population of antigen-specific b cells
SI2164514T1 (sl) 2007-05-21 2017-04-26 Alderbio Holdings Llc Protitelesa proti IL-6 in njihova uporaba
WO2010056898A2 (en) 2008-11-12 2010-05-20 University Of Maryland, Baltimore Rapid expression cloning of human monoclonal antibodies from memory b cells
US8609097B2 (en) * 2009-06-10 2013-12-17 Hoffmann-La Roche Inc. Use of an anti-Tau pS422 antibody for the treatment of brain diseases
CN102686730A (zh) * 2009-11-16 2012-09-19 亚赛特生物技术私人有限公司 重组抗体载体
WO2011112566A2 (en) * 2010-03-11 2011-09-15 Abbott Laboratories Basigin binding proteins
EP2400298B1 (en) * 2010-05-28 2013-08-14 F.Hoffmann-La Roche Ag Single B-cell cultivation method and specific antibody production
MX354049B (es) * 2011-12-21 2018-02-09 Hoffmann La Roche Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados.

Also Published As

Publication number Publication date
MX354049B (es) 2018-02-09
JP6573331B2 (ja) 2019-09-11
MX2014007256A (es) 2014-08-01
JP2019162144A (ja) 2019-09-26
JP2015500655A (ja) 2015-01-08
EP2794652A1 (en) 2014-10-29
CN109810188A (zh) 2019-05-28
JP2017221190A (ja) 2017-12-21
US20140302559A1 (en) 2014-10-09
US20190382469A1 (en) 2019-12-19
RU2612910C2 (ru) 2017-03-13
RU2014128987A (ru) 2016-02-20
CN104011074A (zh) 2014-08-27
US20170210785A1 (en) 2017-07-27
BR112014013034A2 (pt) 2017-12-19
KR20140104963A (ko) 2014-08-29
WO2013092716A1 (en) 2013-06-27
EP2794652B1 (en) 2017-11-15
CA2854243A1 (en) 2013-06-27
SG11201403365TA (en) 2014-07-30

Similar Documents

Publication Publication Date Title
HK1199891A1 (zh) 用於克隆和表達關聯抗體可變區基因區段的快速方法
HK1252157A1 (zh) 重組病毒產品和抑制dux4表達的方法
IL231259A0 (en) A furnace with a high diagnosis and a method of operation
ZA201309287B (en) Methods and compositions for selective regulation of protein expression
PL2752006T3 (pl) Sposób konstruowania listy scalania
EP2691121A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TMPRSS6 GENE
EP2662385A4 (en) METHOD FOR IMPROVING THE PHYSICAL PROPERTIES OF ANTIBODIES
GB201103450D0 (en) Apparatus and method of manipulation of articles
SG11201400405TA (en) Caninised antibodies and method for the production of same
HK1201537A1 (zh) 抗- 抗體和使用方法
IL228073A0 (en) Method for the determination of polysorbate
EP2745678A4 (en) PROCESS FOR CONTROLLING THE REPRODUCTION OF HOPPING
EP2699673A4 (en) RECOMBINANT VIRUS PRODUCTS AND METHODS FOR EXPRESSION INHIBITION OF MYOTILINE
LT2701707T (lt) Diskinezijos gydymo būdas
EP2663662A4 (en) STAHLENTSCHWEFELUNGSVERFAHREN
ZA201306212B (en) An improved process for the preparation of voriconazole and intermediates thereof
EP2726652A4 (en) PROCESS FOR PROTEIN DISPLAY
GB2497108B (en) Laser system and associated method of operation
GB2487128B (en) Carton and method of assembly thereof
HK1184173A1 (zh) 抗- 抗體和使用方法
EP2774995A4 (en) METHOD OF MEASURING THE ABUNDANCE OF GENES
EP2707569A4 (en) DORN ARRANGEMENT AND OPERATING PROCEDURE THEREFOR
AU2011902463A0 (en) Method of Desulfurizing Steel
AU2011905262A0 (en) Method of blasting